 | • レポートコード：QYR2104Z3316 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、腎臓がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、免疫療法、化学療法、放射線療法）、用途別市場規模（腎細胞癌（RCC）、移行上皮癌（TCC））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腎臓がんの市場動向 ・企業の競争状況、市場シェア ・腎臓がんの種類別市場規模（手術、免疫療法、化学療法、放射線療法） ・腎臓がんの用途別市場規模（腎細胞癌（RCC）、移行上皮癌（TCC）） ・腎臓がんの北米市場規模2016-2027（アメリカ、カナダ） ・腎臓がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Novartis、AstraZeneca、Bristol-Myers Squibb、Pfizer、Roche、Amgen、Argos Therapeutics、Aveo Pharmaceuticals、Bayer、Exelixis、Incyte、Allergan） ・結論 |
Market Analysis and Insights: Global Kidney Cancer Market
The global Kidney Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kidney Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kidney Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kidney Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kidney Cancer market.
Global Kidney Cancer Scope and Market Size
Kidney Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Immunotherapy
Chemotherapy
Radiation Therapy
Segment by Application
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bristol-Myers Squibb
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.3 Market by Application
1.3.1 Global Kidney Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Renal Cell Carcinoma (RCC)
1.3.3 Transitional Cell Carcinoma (TCC)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Market Perspective (2016-2027)
2.2 Kidney Cancer Growth Trends by Regions
2.2.1 Kidney Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kidney Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Kidney Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Kidney Cancer Industry Dynamic
2.3.1 Kidney Cancer Market Trends
2.3.2 Kidney Cancer Market Drivers
2.3.3 Kidney Cancer Market Challenges
2.3.4 Kidney Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Players by Revenue
3.1.1 Global Top Kidney Cancer Players by Revenue (2016-2021)
3.1.2 Global Kidney Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Revenue
3.4 Global Kidney Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2020
3.5 Kidney Cancer Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Product Solution and Service
3.7 Date of Enter into Kidney Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Breakdown Data by Type
4.1 Global Kidney Cancer Historic Market Size by Type (2016-2021)
4.2 Global Kidney Cancer Forecasted Market Size by Type (2022-2027)
5 Kidney Cancer Breakdown Data by Application
5.1 Global Kidney Cancer Historic Market Size by Application (2016-2021)
5.2 Global Kidney Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Kidney Cancer Market Size (2016-2027)
6.2 North America Kidney Cancer Market Size by Type
6.2.1 North America Kidney Cancer Market Size by Type (2016-2021)
6.2.2 North America Kidney Cancer Market Size by Type (2022-2027)
6.2.3 North America Kidney Cancer Market Size by Type (2016-2027)
6.3 North America Kidney Cancer Market Size by Application
6.3.1 North America Kidney Cancer Market Size by Application (2016-2021)
6.3.2 North America Kidney Cancer Market Size by Application (2022-2027)
6.3.3 North America Kidney Cancer Market Size by Application (2016-2027)
6.4 North America Kidney Cancer Market Size by Country
6.4.1 North America Kidney Cancer Market Size by Country (2016-2021)
6.4.2 North America Kidney Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Kidney Cancer Market Size (2016-2027)
7.2 Europe Kidney Cancer Market Size by Type
7.2.1 Europe Kidney Cancer Market Size by Type (2016-2021)
7.2.2 Europe Kidney Cancer Market Size by Type (2022-2027)
7.2.3 Europe Kidney Cancer Market Size by Type (2016-2027)
7.3 Europe Kidney Cancer Market Size by Application
7.3.1 Europe Kidney Cancer Market Size by Application (2016-2021)
7.3.2 Europe Kidney Cancer Market Size by Application (2022-2027)
7.3.3 Europe Kidney Cancer Market Size by Application (2016-2027)
7.4 Europe Kidney Cancer Market Size by Country
7.4.1 Europe Kidney Cancer Market Size by Country (2016-2021)
7.4.2 Europe Kidney Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Market Size (2016-2027)
8.2 Asia-Pacific Kidney Cancer Market Size by Type
8.2.1 Asia-Pacific Kidney Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kidney Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kidney Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Kidney Cancer Market Size by Application
8.3.1 Asia-Pacific Kidney Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kidney Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kidney Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Kidney Cancer Market Size by Region
8.4.1 Asia-Pacific Kidney Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kidney Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Kidney Cancer Market Size (2016-2027)
9.2 Latin America Kidney Cancer Market Size by Type
9.2.1 Latin America Kidney Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Kidney Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Kidney Cancer Market Size by Type (2016-2027)
9.3 Latin America Kidney Cancer Market Size by Application
9.3.1 Latin America Kidney Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Kidney Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Kidney Cancer Market Size by Application (2016-2027)
9.4 Latin America Kidney Cancer Market Size by Country
9.4.1 Latin America Kidney Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Kidney Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Market Size (2016-2027)
10.2 Middle East & Africa Kidney Cancer Market Size by Type
10.2.1 Middle East & Africa Kidney Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kidney Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kidney Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Kidney Cancer Market Size by Application
10.3.1 Middle East & Africa Kidney Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kidney Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kidney Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Kidney Cancer Market Size by Country
10.4.1 Middle East & Africa Kidney Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kidney Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Introduction
11.1.4 Merck Revenue in Kidney Cancer Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Introduction
11.2.4 Novartis Revenue in Kidney Cancer Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Kidney Cancer Introduction
11.3.4 AstraZeneca Revenue in Kidney Cancer Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Kidney Cancer Introduction
11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Kidney Cancer Introduction
11.5.4 Pfizer Revenue in Kidney Cancer Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Kidney Cancer Introduction
11.6.4 Roche Revenue in Kidney Cancer Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Kidney Cancer Introduction
11.7.4 Amgen Revenue in Kidney Cancer Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Argos Therapeutics
11.8.1 Argos Therapeutics Company Details
11.8.2 Argos Therapeutics Business Overview
11.8.3 Argos Therapeutics Kidney Cancer Introduction
11.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2016-2021)
11.8.5 Argos Therapeutics Recent Development
11.9 Aveo Pharmaceuticals
11.9.1 Aveo Pharmaceuticals Company Details
11.9.2 Aveo Pharmaceuticals Business Overview
11.9.3 Aveo Pharmaceuticals Kidney Cancer Introduction
11.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2016-2021)
11.9.5 Aveo Pharmaceuticals Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Kidney Cancer Introduction
11.10.4 Bayer Revenue in Kidney Cancer Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Exelixis
11.11.1 Exelixis Company Details
11.11.2 Exelixis Business Overview
11.11.3 Exelixis Kidney Cancer Introduction
11.11.4 Exelixis Revenue in Kidney Cancer Business (2016-2021)
11.11.5 Exelixis Recent Development
11.12 Incyte
11.12.1 Incyte Company Details
11.12.2 Incyte Business Overview
11.12.3 Incyte Kidney Cancer Introduction
11.12.4 Incyte Revenue in Kidney Cancer Business (2016-2021)
11.12.5 Incyte Recent Development
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Kidney Cancer Introduction
11.13.4 Allergan Revenue in Kidney Cancer Business (2016-2021)
11.13.5 Allergan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Radiation Therapy
Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Kidney Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Kidney Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Kidney Cancer Market Share by Regions (2016-2021)
Table 10. Global Kidney Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Kidney Cancer Market Share by Regions (2022-2027)
Table 12. Kidney Cancer Market Trends
Table 13. Kidney Cancer Market Drivers
Table 14. Kidney Cancer Market Challenges
Table 15. Kidney Cancer Market Restraints
Table 16. Global Kidney Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Kidney Cancer Market Share by Players (2016-2021)
Table 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2020)
Table 19. Ranking of Global Top Kidney Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kidney Cancer Product Solution and Service
Table 23. Date of Enter into Kidney Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Kidney Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Kidney Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Kidney Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Kidney Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Kidney Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Kidney Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Kidney Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Kidney Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Kidney Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Kidney Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Kidney Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Kidney Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Kidney Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Kidney Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Kidney Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Kidney Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Kidney Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Kidney Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kidney Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Kidney Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Kidney Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Kidney Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Kidney Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Kidney Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Kidney Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Kidney Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Kidney Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Kidney Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Kidney Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kidney Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Kidney Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Kidney Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Kidney Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Kidney Cancer Product
Table 66. Merck Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Kidney Cancer Product
Table 71. Novartis Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Kidney Cancer Product
Table 76. AstraZeneca Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Kidney Cancer Product
Table 81. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Kidney Cancer Product
Table 86. Pfizer Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Kidney Cancer Product
Table 91. Roche Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Kidney Cancer Product
Table 96. Amgen Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Argos Therapeutics Company Details
Table 99. Argos Therapeutics Business Overview
Table 100. Argos Therapeutics Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 101. Argos Therapeutics Recent Development
Table 102. Aveo Pharmaceuticals Company Details
Table 103. Aveo Pharmaceuticals Business Overview
Table 104. Aveo Pharmaceuticals Kidney Cancer Product
Table 105. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 106. Aveo Pharmaceuticals Recent Development
Table 107. Bayer Company Details
Table 108. Bayer Business Overview
Table 109. Bayer Kidney Cancer Product
Table 110. Bayer Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 111. Bayer Recent Development
Table 112. Exelixis Company Details
Table 113. Exelixis Business Overview
Table 114. Exelixis Kidney Cancer Product
Table 115. Exelixis Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 116. Exelixis Recent Development
Table 117. Incyte Company Details
Table 118. Incyte Business Overview
Table 119. Incyte Kidney Cancer Product
Table 120. Incyte Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 121. Incyte Recent Development
Table 122. Allergan Company Details
Table 123. Allergan Business Overview
Table 124. Allergan Kidney Cancer Product
Table 125. Allergan Revenue in Kidney Cancer Business (2016-2021) & (US$ Million)
Table 126. Allergan Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Kidney Cancer Market Share by Application: 2020 VS 2027
Figure 7. Renal Cell Carcinoma (RCC) Case Studies
Figure 8. Transitional Cell Carcinoma (TCC) Case Studies
Figure 9. Kidney Cancer Report Years Considered
Figure 10. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Kidney Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Kidney Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Kidney Cancer Market Share by Regions (2022-2027)
Figure 14. Global Kidney Cancer Market Share by Players in 2020
Figure 15. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2020
Figure 17. Global Kidney Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Kidney Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Kidney Cancer Market Share by Type (2016-2027)
Figure 21. North America Kidney Cancer Market Share by Application (2016-2027)
Figure 22. North America Kidney Cancer Market Share by Country (2016-2027)
Figure 23. United States Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Kidney Cancer Market Share by Type (2016-2027)
Figure 27. Europe Kidney Cancer Market Share by Application (2016-2027)
Figure 28. Europe Kidney Cancer Market Share by Country (2016-2027)
Figure 29. Germany Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Kidney Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Kidney Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Kidney Cancer Market Share by Region (2016-2027)
Figure 39. China Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Kidney Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Kidney Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Kidney Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Kidney Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Kidney Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Kidney Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Kidney Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 65. Argos Therapeutics Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 66. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 68. Exelixis Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 69. Incyte Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in Kidney Cancer Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の進行腎細胞がん治療市場規模・現状・予測（2021年-2027年） Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …- 世界の腎臓がん治療・診断市場規模・現状・予測（2021年-2027年） The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC).Immunotherapies or targe…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…
- 世界の移行細胞がん治療薬市場規模・現状・予測（2021年-2027年） Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra. Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. Mar…